DEXTROSE
Pain, Chronic
National and Kapodistrian University of AthensmixturePhase 2/3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 89/ 100
Competitive context
18 Active assets in the Pain, Chronic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Bxcl501 Peking Union Medical College Hospital | Phase 4 | A |
PROPOFOL Oregon Health and Science University | Phase 4 | BBB |
METHADONE Cari Health Inc. | Phase 4 | BBB |
DEXTROSE SOLUTION Kastamonu University | Phase 4 | BB |
Cymbalta Hospital for Special Surgery, New York | Phase 4 | BB |
View all 32 →
Same molecule, other indications
DEXTROSE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →